Colchicine fails to improve knee pain, function, or size of synovial effusions with painful knee osteoarthritis (OA), ...

For patients with immunoglobulin G (IgG)4-related disease, inebilizumab reduces the risk for flares and increases the ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

A trio of abstracts presented at ACR Convergence 2024, the annual meeting of the American College of Rheumatology, bear out the benefits of bimekizumab (Bimzelx; UCB Pharma) for use against active ...

The amphitheater project kicked off with a million dollar grant from the ACR Area Development program. The plan is to build a ...

Long-term treatment with anifrolumab significantly reduced the rate of organ damage compared with SOC among patients with SLE ...

More than half the women in the treat-to-target group conceived within 3 months vs a median of 6.5 months for those in the ...

One mum-of-two is already £2,000 better off after switching from central heating to a log burner - and says she doesn't even ...

Most patients with rheumatoid arthritis or spondyloarthritis had significant antibody responses to COVID vaccine boosters, whether or not their immunomodulatory medications were held.

The Punjab government on Tuesday annou­n­ced the reopening of all schools acr­oss the province from November 20 (Wednesday), ...

The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...